What happens when you take probiotics with immunosuppressants?
Probiotics are live microorganisms, most often Lactobacillus, Bifidobacterium, or Saccharomyces boulardii, that are taken to support gut and immune health. In a person with a normal immune system, these organisms are usually contained within the gastrointestinal tract and pose very little risk. Immunosuppressant medications, including tacrolimus, cyclosporine, sirolimus, everolimus, mycophenolate mofetil, azathioprine, and chronic corticosteroids such as prednisone, are designed to blunt the body's immune response so that a transplanted organ is not rejected or so that an autoimmune disease can be controlled.
When the immune system is deliberately weakened, the same probiotic organisms that are harmless in a healthy gut can occasionally cross the intestinal barrier and enter the bloodstream. This phenomenon is called bacterial translocation. Once in the bloodstream, probiotic strains have been shown to cause bacteremia, endocarditis, liver abscesses, and full-blown sepsis. The published literature includes a growing list of case reports and a matched case-control study showing that probiotic supplementation is associated with these invasive infections in immunocompromised hosts.
Why is this important?
Manufacturers market probiotics as foods or dietary supplements, which means they do not carry the same warning labels as prescription drugs. Many patients on immunosuppressants assume that anything sold over the counter, especially something described as natural, must be safe. That assumption can be dangerous. Transplant recipients, patients on high-dose steroids, people with advanced HIV, and patients receiving biologic therapy for autoimmune disease all have a measurably increased risk of opportunistic bloodstream infection.
The infections are also difficult to treat. Many probiotic-derived Lactobacillus strains are intrinsically resistant to vancomycin, which is a first-line antibiotic for gram-positive bacteremia. Identification of the organism in blood cultures can be delayed because clinicians do not always recognize lactobacilli or bifidobacteria as true pathogens. By the time the probiotic origin is identified, the patient may already be critically ill.
A second concern is that probiotics may interact with the gut microbiome in ways that influence drug absorption. Some immunosuppressants, including tacrolimus, are metabolized by intestinal CYP3A4 and P-glycoprotein, which can be modulated by the resident microbiota. While the clinical significance of this is still being studied, transplant programs typically prefer to keep the microbiome as stable and predictable as possible.
What should you do?
If you are taking any immunosuppressant medication, do not start a probiotic supplement without first speaking to your transplant team, rheumatologist, or oncologist. This includes capsule and powder probiotics from the pharmacy as well as probiotic drinks, shots, and powders sold as health foods. The same caution applies to Saccharomyces boulardii, which is a yeast and can cause fungemia in immunocompromised hosts.
If your physician has specifically prescribed a probiotic, take it exactly as directed and report any new fever, chills, abdominal pain, or signs of infection promptly. Avoid handling probiotic capsules near central venous catheters, because contamination of the catheter site has been linked to bloodstream infection. If you are caring for an immunocompromised person at home, wash hands thoroughly after taking your own probiotic capsule before contact.
Fermented foods such as plain yogurt and traditional cheeses contain lower live counts than concentrated supplements and are usually permitted, but heavily fermented products such as kombucha, raw kefir, and unpasteurized sauerkraut should also be discussed with the prescribing team. Hospitals increasingly ban probiotic products in transplant and oncology wards for exactly these reasons.
Which specific products are affected?
The concern applies broadly to multi-strain probiotic supplements that contain Lactobacillus rhamnosus GG, Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium species, Streptococcus thermophilus, and Saccharomyces boulardii. Popular brands sold for general gut health, antibiotic-associated diarrhea, or immune support all fall under this caution when used with immunosuppressants.
Immunosuppressants of concern include tacrolimus, cyclosporine, sirolimus, everolimus, mycophenolate mofetil, azathioprine, methotrexate at immunosuppressive doses, chronic systemic corticosteroids, and biologic agents such as rituximab, infliximab, adalimumab, and other monoclonal antibodies that suppress immune function. Patients receiving chemotherapy for solid tumors or hematologic malignancies should be considered in the same category, particularly during neutropenia.
The bottom line
Probiotics are not a one-size-fits-all supplement. For people on immunosuppressant therapy, the same live organisms that benefit healthy users can become bloodstream pathogens. The risk is rare in absolute terms but well documented, and the consequences are serious. If you are immunosuppressed for any reason, treat probiotic supplements as you would any prescription decision and clear them with your physician first.